ADAG Stock Analysis: Buy, Sell, or Hold?

ADAG - Adagene Inc. American Depositary Shares

Pharmaceutical Preparations
$3.93
0.00 (0.00%) ▲
5d: -7.09%
30d: +9.78%
90d: -9.03%
HOLD
LOW Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Apr 01, 2026 0d

Get Alerted When ADAG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ADAG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ADAG is currently trading at $3.93, which is considered extended relative to its 30-day fair value range of $3.43 to $4.14.

Technical Outlook: Technically, ADAG is in a uptrend. Immediate support is located at $3.32, while resistance sits at $4.85.

Market Sentiment: ADAG has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.40 (+139.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $3.43 - $4.14
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 63.2%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 139.2% below Wall St target ($9.40)
  • CAUTION: Recommendation downgraded due to -7.1% 5-day decline

Trading Range Analysis

30-Day Trading Range $3.43 - $4.14
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $3.32
Resistance Level $4.85
Current Trend Uptrend
Technical data as of Jul 7, 2026

Fundamental Context

Forward P/E (Next Year Est.) -7.56
Wall Street Target $9.40 (+139.2%)
Revenue Growth (YoY) 7332.8%
Profit Margin -229.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 08, 2026 2:32 AM ET
Data refreshes hourly during market hours. Next update: 3:32 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ADAG.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$435 58 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 59 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$102 59 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 57 HOLD
BHVN
Biohaven Ltd.
STRONG BUY
16 analysts
$22 60 BUY

More Analysis for ADAG

ADAG Technical Chart ADAG Price Prediction ADAG Earnings Date ADAG Investment Advisor ADAG Fair Price Analyzer ADAG Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals